Stanford gains access to Twist's 'library of libraries'

By The Science Advisory Board staff writers

April 7, 2021 -- Twist Bioscience has granted Stanford University access to its antibody discovery and optimization services and its "library of libraries" for biologics discovery.

Researchers from Stanford's Innovative Medicines Accelerator program will have access to the library, which consists of a range of preconstructed and validated synthetic antibody libraries and proprietary discovery and optimization capabilities of Twist Biopharma, a division of Twist Bioscience.

Twist and Stanford hope that the newly granted access to these resources will accelerate antibody discovery against a wide range of therapeutic targets.

Financial details of the deal were not disclosed.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.